DexCom Inc. (NASDAQ: DXCM) started the day on November 23, 2022, with a price increase of 1.72% at $112.92. During the day, the stock rose to $113.335 and sunk to $110.60 before settling in for the price of $111.01 at the close. Taking a more long-term approach, DXCM posted a 52-week range of $66.89-$154.51.
Do You Own These 7 Inflation-Survival Stocks?
Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.
Click here to get your free copy of the report
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 33.70%. Meanwhile, its Annual Earning per share during the time was 31.70%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -69.50%. This publicly-traded company’s shares outstanding now amounts to $389.80 million, simultaneously with a float of $382.65 million. The organization now has a market capitalization sitting at $43.20 billion. At the time of writing, stock’s 50-day Moving Average stood at $100.97, while the 200-day Moving Average is $95.07.
While finding the extent of efficiency of the company that is accounted for 6300 employees. For the Profitability, stocks gross margin was +68.63, operating margin was +10.86 and Pretax Margin of +7.10.
DexCom Inc. (DXCM) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Diagnostics & Research Industry. DexCom Inc.’s current insider ownership accounts for 0.10%, in contrast to 98.40% institutional ownership. According to the most recent insider trade that took place on Nov 21, this organization’s EVP Chief Financial Officer sold 2,400 shares at the rate of 112.62, making the entire transaction reach 270,288 in total value, affecting insider ownership by 67,237. Preceding that transaction, on Sep 01, Company’s SVP Corporate Strategy-Develop sold 5 for 81.63, making the whole transaction’s value amount to 408. This particular insider is now the holder of 26,536 in total.
DexCom Inc. (DXCM) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 9/29/2022, the organization reported $0.28 earnings per share (EPS) for the three months, surpassing the consensus estimate (set at $0.24) by $0.04. This company achieved a net margin of +6.32 while generating a return on equity of 7.59. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.18 per share during the current fiscal year.
DexCom Inc.’s EPS decrease for this current 12-month fiscal period is -69.50% and is forecasted to reach 1.08 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 32.90% through the next 5 years, which can be compared against the 31.70% growth it accomplished over the previous five years trading on the market.
DexCom Inc. (NASDAQ: DXCM) Trading Performance Indicators
Let’s observe the current performance indicators for DexCom Inc. (DXCM). It’s Quick Ratio in the last reported quarter now stands at 3.40. The Stock has managed to achieve an average true range (ATR) of 4.40. Alongside those numbers, its PE Ratio stands at $211.07, and its Beta score is 1.16. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 15.47. Similarly, its price to free cash flow for trailing twelve months is now 165.34.
In the same vein, DXCM’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.54, a figure that is expected to reach 0.27 in the next quarter, and analysts are predicting that it will be 1.08 at the market close of one year from today.
Technical Analysis of DexCom Inc. (DXCM)
If we take a close look at the recent performances of DexCom Inc. (NASDAQ: DXCM), its last 5-days Average volume was 2.41 million that shows plunge from its year to date volume of 3.22 million. During the previous 9 days, stock’s Stochastic %D was recorded 12.16% While, its Average True Range was 4.00.